The Research and Development team at Fusion Pharmaceuticals is dedicated to discovering and advancing next-generation radiopharmaceuticals for precision oncology. This multidisciplinary team of scientists, including clinical and computational experts, conducts innovative research, develops cutting-edge technologies, and collaborates with regulatory specialists to ensure the safe and effective progression of new therapies through clinical trials. Their goal is to transform cancer treatment by harnessing the power of targeted radiopharmaceuticals.
Anusha Bollimuntha
Scientist, Microbiology
Christopher Kuc
Research Associate II
Christopher Leamon
Chief Scientific Officer
Julie Metcalf
Senior Scientist
Kevin Chathely
Research Associate
Nicole McFarlane
Research Associate II
Pauline Negre
Research Associate II
Rishikesh Katkar
Research Associate
Sadaf Aghevlian
Computational Scientist
Sean Collens
Senior Research Associate II
View all